Yung Hee Park

Title: Yung Hee Park: Innovator in Gene Therapy for Parkinson's Disease

Introduction

Yung Hee Park is a notable inventor based in Lexington, MA (US). He has made significant contributions to the field of gene therapy, particularly in the treatment of neurodegenerative disorders such as Parkinson's disease. His innovative approach focuses on the use of glucocerebrosidase enzyme to provide therapeutic benefits to affected individuals.

Latest Patents

Yung Hee Park holds 1 patent for his invention titled "Glucocerebrosidase gene therapy for Parkinson's disease." This patent outlines a method for treating subjects with neurodegenerative disorders by administering glucocerebrosidase enzyme, either through gene therapy or direct protein administration. The invention emphasizes the potential of glucocerebrosidase nucleic acids or proteins in treating Parkinson's disease and other related conditions.

Career Highlights

Throughout his career, Yung Hee Park has worked with esteemed organizations, including McLean Hospital Corporation and Shire Human Genetic Therapies, Inc. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research in gene therapy.

Collaborations

Yung Hee Park has collaborated with notable professionals, including Ole Isacson, to advance research in neurodegenerative disorders. Their combined expertise has fostered innovative approaches to treatment and has the potential to improve the lives of many patients.

Conclusion

Yung Hee Park's work in gene therapy represents a significant advancement in the treatment of Parkinson's disease. His innovative methods and collaborations highlight the importance of research in developing effective therapies for neurodegenerative disorders.